We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

CRISPR and Stem Cells Help Identify New Chlamydia Drug Targets

News   Apr 26, 2017 | Original story from the Wellcome Trust

 
CRISPR and Stem Cells Help Identify New Chlamydia Drug Targets

A human macrophage interacting with a chlamydia cell. Credit: Sanger Institute, Genome Research Limited

 
 
Advertisement
 

RELATED ARTICLES

Adaptate Biotherapeutics Appoints Stewart Kay as Chief Business Officer

News

Adaptate Biotherapeutics (Adaptate) today announced the appointment of Stewart Kay as Chief Business Officer (CBO).

READ MORE

Possible Role For Newly Discovered Immune Cell Population in MS

News

A team of investigators at Thomas Jefferson University have characterized a new population of T cells called ThGM cells that produce granulocyte macrophage-colony-stimulating factor (GM-CSF). The team has now uncovered key defining features of these cells and how they behave in an animal model of MS.

READ MORE

Investigational Drug Safely Slows Progression of Diabetic Kidney Disease in Clinical Trial

News

Patients with diabetic kidney disease could potentially be treated with an investigational new drug that may slow the progress of their illness without harmful adverse effects to their hearts, according to the results of a recent global clinical trial.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Diagnostics Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE